🩺 Text2MD Annual Membership
Virtual Direct Primary Care — Built Around You
The Text2MD Annual Membership provides ongoing virtual primary care with a board-certified internal medicine physician — focused on continuity of care, prevention, metabolic health, and long-term optimization.
This is not insurance-based, high-volume care.
We cap at 400 patients per year, insurance based providers panel extend to 3,000 or more.Â
This is structured, physician-guided medicine delivered virtually.
Â
What the Membership Includes
✔ Virtual Text consultations throughout the year
✔ Secure messaging for non-urgent medical guidance
✔ Chronic condition management and preventive care
✔ Metabolic and cardiovascular risk evaluation
✔ Annual Laboratory Blood-Work included: Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), Lipid profile (Cholesterol), A1C (Glucose trend), Thyroid Stimulating Hormone (TSH).Â
✔ Weight Loss, Hormonal and midlife health support
✔ GLP-1 assessment, treatment, monitoring and structured follow-up
✔ Special Member pricing on selected programs, medications, peptides, labs, and supplements (GLP-1 program starting at $77/month)
✔Three 20-minute physician video consultations per year included​
​(Standard non-member rate: $125 per visit.)
✔ Access to off-label therapies when medically appropriate
✔ Access to AvidaMD Health Education LibraryÂ
✔  Text2MD Metabolic Health Tools (weight loss calculator, plateau calculator, hormonal weight resistance score and more..)
✔ We are expanding and introducing additional benefits throughout the year
Designed for Modern Primary Care
Instead of rushed visits and fragmented communication, your membership provides:
Direct Physician Access
Communicate directly with your doctor — no call centers, no layers of staff.Â
Transparent Pricing
One annual fee covers your virtual primary care services.
Proactive, Not Reactive Care
Focus on prevention, metabolic optimization, and long-term health — not just sick visits.
Continuity
Ongoing monitoring, follow-up, and adjustments tailored to your goals.
Who This Is For
 ✔ Patients seeking consistent physician access
✔ Individuals managing weight, metabolic health, or chronic conditions
✔ Those using GLP-1 or hormonal therapy who want structured oversight
✔ Adults who want preventive, relationship-based care
Important to Know
The Text2MD Membership covers virtual physician primary care services.
Hospitalizations, medications, imaging, specialist visits, and procedures should be covered by insurance, a health-sharing plan or out-of-pocket.
A Different Kind of Primary Care
Text2MD combines:
• Internal medicine expertise
• Metabolic and hormonal focus
• Direct virtual access
• Transparent pricing
Care that is personal. Accessible. Structured. Ongoing.
Text2MD Blog

What If Your Body Were a $500 Million Machine?
Imagine you were given a $500 million machine. It runs continuously.It powers your cognition, movement, and immunity.It self-repairs.It adapts to stress.With proper maintenance, it can

Why Cortisol Makes Menopausal Weight Loss So Hard — and What You Can Do About It
A Physician-Guided Approach to Hormonal Weight Loss at Text2MD Struggling to lose weight during menopause?If you’re eating well, exercising, and still gaining weight—especially around your

Sugar, Inflammation, and Long COVID: What You Need to Know
Many people with Long COVID continue to experience symptoms like fatigue, brain fog, joint pain, or exercise intolerance even after standard lab tests appear normal.

Understanding the Link Between Long Covid, Fatigue, and Hormonal Imbalance
I. Introduction: When Rest Isn’t Enough In the months following a COVID-19 infection, a peculiar and deeply frustrating pattern has emerged for many individuals —

5 Reasons Why Sermorelin Could Be the Key to Your Weight Loss Goals!
Introduction: Could Sermorelin Be the Missing Link in Weight Loss? For decades, the weight loss industry has largely focused on diet and exercise as

GLP-1 Medications: A Game Changer for Brain Health Beyond Weight Loss
In recent years, GLP-1 receptor agonists—such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda)—have revolutionized the treatment of type 2 diabetes and obesity. However, emerging research



